ARAP1 and pancreatic adenocarcinoma: Notably, in pancreatic adenocarcinoma (PAAD) and uterine carcinosarcoma (UCS), ARAP1-AS1 demonstrated an AUC exceeding 0.9, highlighting its significant diagnostic promise (Fig. 6).